PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 46
- Registration Number
- NCT05203172
- Locations
- 🇺🇸
St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸HealthPartners Cancer Research Center, Saint Paul, Minnesota, United States
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2025-06-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 1
- Registration Number
- NCT05198245
- Locations
- 🇺🇸
Research Triangle Institute d/b/a RTI Health Solutions, Research Triangle Park, North Carolina, United States
A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis
- Conditions
- Psoriatic Arthritis
- First Posted Date
- 2022-01-19
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 141
- Registration Number
- NCT05195814
- Locations
- 🇺🇸
Pfizer, New York, New York, United States
Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefilled Syringe
- Conditions
- Healthy Volunteers
- Interventions
- Combination Product: PF-06881894 by on-body injectorCombination Product: PF-06881894 by prefilled syringe
- First Posted Date
- 2022-01-18
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 141
- Registration Number
- NCT05194579
- Locations
- 🇺🇸
Research Centers of America ( Hollywood ), Hollywood, Florida, United States
🇺🇸Anaheim Clinical Trials, LLC, Anaheim, California, United States
🇺🇸Prism Research LLC dba Nucleus Network, Saint Paul, Minnesota, United States
An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study
- Conditions
- Dermatomyositis
- Interventions
- Drug: Anti-Beta Interferon (PF-06823859)
- First Posted Date
- 2022-01-14
- Last Posted Date
- 2025-02-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT05192200
- Locations
- 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
🇭🇺Debreceni Egyetem Klinikai Kozpont, Debrecen, Hungary
A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia
- First Posted Date
- 2022-01-12
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 165
- Registration Number
- NCT05189639
- Locations
- 🇰🇷
Seoul national university hospital, Seoul, Korea, Republic of
Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.
- Conditions
- Healthy Participants
- Interventions
- Drug: [14C]PF-07321332
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Pfizer
- Registration Number
- NCT05178654
Latin American Real-world Study in Acute Leukemia
- Conditions
- Acute Lymphoid LeukemiaAcute Myeloid Leukemia
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 589
- Registration Number
- NCT05166135
- Locations
- 🇧🇷
Hospital Beneficência Portuguesa de São Paulo, São Paulo, Brazil
🇨🇱Hospital Guillermo Grant Benavente, Concepcion, Chile
🇦🇷Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina
Crizotinib Continuation Clinical Study
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 26
- Registration Number
- NCT05160922
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China
🇨🇳Beijing Cancer Hospital, Beijing, Beijing, China
🇨🇳Fujian Province Oncology Hospital, Fuzhou, Fujian, China
Patient Reported Health-Related Quality of Life Associated With COVID-19
- Conditions
- COVID-19Coronavirus Disease 2019Influenza
- Interventions
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2025-05-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 999
- Registration Number
- NCT05160636
- Locations
- 🇺🇸
CVS Health, Woonsocket, Rhode Island, United States